Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Goodwill & Intangibles (2016 - 2025)

IGC Pharma (IGC) has disclosed Goodwill & Intangibles for 15 consecutive years, with $566000.0 as the latest value for Q3 2025.

  • Quarterly Goodwill & Intangibles fell 1.91% to $566000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $566000.0 through Sep 2025, down 1.91% year-over-year, with the annual reading at $1.5 million for FY2025, 116.69% up from the prior year.
  • Goodwill & Intangibles for Q3 2025 was $566000.0 at IGC Pharma, down from $1.7 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $1.7 million in Q2 2025, with the low at $181000.0 in Q1 2021.
  • Average Goodwill & Intangibles over 5 years is $610000.0, with a median of $566000.0 recorded in 2025.
  • The sharpest move saw Goodwill & Intangibles fell 28.17% in 2021, then surged 145.83% in 2025.
  • Over 5 years, Goodwill & Intangibles stood at $426000.0 in 2021, then rose by 28.17% to $546000.0 in 2022, then increased by 5.31% to $575000.0 in 2023, then dropped by 0.7% to $571000.0 in 2024, then fell by 0.88% to $566000.0 in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $566000.0, $1.7 million, and $1.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.